24/7 Market News Snapshot 07 August, 2025 – Phathom Pharmaceuticals, Inc. Common Stock (NASDAQ:PHAT)

August 7, 2025

DENVER, Colo., 07 August, 2025 (www.247marketnews.com) – (Nasdaq:PHAT) are discussed in this article.
Phathom Pharmaceuticals, Inc. (Nasdaq:PHAT) is experiencing significant trading activity today, starting at a price of $9.21 and rising to approximately $9.63, reflecting an impressive increase of around 11% based on the previous closing price of $8.68. With a trading volume of 1.71 million shares, there is notable investor interest, which may reflect positive sentiment about the company’s recent developments and overall prospects. Market observers are advised to keep an eye on resistance levels around the $10 mark and support near the opening price as the trading session progresses.

In conjunction with this trading development, Phathom has reported exceptional financial results for the second quarter of 2025. The company achieved net revenues of $39.5 million, a dramatic 441% increase from the same period last year, largely attributed to the robust sales of its primary product, VOQUEZNA®. As of now, over 580,000 prescriptions for VOQUEZNA have been filled, with nearly 173,000 occurring in the last quarter alone, marking a 36% rise since the prior quarter. This growth is fueled by increasing adoption rates among healthcare providers, as evidenced by over 29,300 unique prescribers.

Phathom’s President and CEO, Steve Basta, expressed enthusiasm regarding the company’s trajectory, highlighting the effectiveness of their strategic adjustments and market focus. The firm has also revised its revenue guidance for the full year 2025, projecting between $165 million and $175 million, as it aims for profitability by 2026. The implementation of cost-saving measures has led to a reduction in non-GAAP operating expenses, further supporting its financial strategy.

As the company continues to navigate the pharmaceutical landscape, it is poised for ongoing growth, supported by both market interest and strong financial performance.

Related news for (PHAT)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.